Literature DB >> 18853253

Analysis of N-glycans in embryonated chicken egg chorioallantoic and amniotic cells responsible for binding and adaptation of human and avian influenza viruses.

Nongluk Sriwilaijaroen1, Sachiko Kondo, Hirokazu Yagi, Prapon Wilairat, Hiroaki Hiramatsu, Morihiro Ito, Yasuhiko Ito, Koichi Kato, Yasuo Suzuki.   

Abstract

The initial step essential in influenza virus infection is specific binding of viral hemagglutinin to host cell-surface glycan receptors. Influenza A virus specificity for the host is mediated by viral envelope hemagglutinin, that binds to receptors containing glycans with terminal sialic acids. Human viruses preferentially bind to alpha2-->6 linked sialic acids on receptors of host cells, whereas avian viruses are specific for the alpha2-->3 linkage on the target cells. Human influenza virus isolates more efficiently infect amniotic membrane (AM) cells than chorioallantoic membrane (CAM) cells. N-glycans were isolated from AM and CAM cells of 10-day-old chicken embryonated eggs and their structures were analyzed by multi-dimensional HPLC mapping and MALDI-TOF-MS techniques. Terminal N-acetylneuraminic acid contents in the two cell types were similar. However, molar percents of alpha2-->3 linkage preferentially bound by avian influenza virus were 27.2 in CAM cells and 15.4 in AM cells, whereas those of alpha2-->6 linkage favored by human influenza virus were 8.3 (CAM) and 14.2 (AM). Molar percents of sulfated glycans, recognized by human influenza virus, in CAM and AM cells were 3.8 and 12.7, respectively. These results have revealed structures and molar percents of N-glycans in CAM and AM cells important in determining human and avian influenza virus infection and viral adaptation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18853253     DOI: 10.1007/s10719-008-9193-x

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  49 in total

1.  Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus.

Authors:  J M Katz; M Wang; R G Webster
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

2.  Characterization of a human H5N1 influenza A virus isolated in 2003.

Authors:  Kyoko Shinya; Masato Hatta; Shinya Yamada; Ayato Takada; Shinji Watanabe; Peter Halfmann; Taisuke Horimoto; Gabriele Neumann; Jin Hyun Kim; Wilina Lim; Yi Guan; Malik Peiris; Makoto Kiso; Takashi Suzuki; Yasuo Suzuki; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  The hemagglutinin of influenza B virus present in clinical material is a single species identical to that of mammalian cell-grown virus.

Authors:  J S Robertson; J S Bootman; C Nicolson; D Major; E W Robertson; J M Wood
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

4.  Involvement of the mannose receptor in infection of macrophages by influenza virus.

Authors:  P C Reading; J L Miller; E M Anders
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

5.  Structures of the sugar chains of interferon-gamma produced by human myelomonocyte cell line HBL-38.

Authors:  S Yamamoto; S Hase; S Fukuda; O Sano; T Ikenaka
Journal:  J Biochem       Date:  1989-04       Impact factor: 3.387

6.  The quail and chicken intestine have sialyl-galactose sugar chains responsible for the binding of influenza A viruses to human type receptors.

Authors:  Chao-Tan Guo; Noriko Takahashi; Hirokazu Yagi; Koichi Kato; Tadanobu Takahashi; Shuang-Qin Yi; Yong Chen; Toshihiro Ito; Koichi Otsuki; Hiroshi Kida; Yoshihiro Kawaoka; Kazuya I-P Jwa Hidari; Daisei Miyamoto; Takashi Suzuki; Yasuo Suzuki
Journal:  Glycobiology       Date:  2007-03-27       Impact factor: 4.313

7.  Influenza virus entry and infection require host cell N-linked glycoprotein.

Authors:  Victor C Chu; Gary R Whittaker
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-15       Impact factor: 11.205

8.  Avian flu: isolation of drug-resistant H5N1 virus.

Authors:  Q Mai Le; Maki Kiso; Kazuhiko Someya; Yuko T Sakai; T Hien Nguyen; Khan H L Nguyen; N Dinh Pham; Ha H Ngyen; Shinya Yamada; Yukiko Muramoto; Taisuke Horimoto; Ayato Takada; Hideo Goto; Takashi Suzuki; Yasuo Suzuki; Yoshihiro Kawaoka
Journal:  Nature       Date:  2005-10-20       Impact factor: 49.962

9.  Human-specific regulation of alpha 2-6-linked sialic acids.

Authors:  Pascal Gagneux; Monica Cheriyan; Nancy Hurtado-Ziola; Els C M Brinkman van der Linden; Dan Anderson; Harold McClure; Ajit Varki; Nissi M Varki
Journal:  J Biol Chem       Date:  2003-09-18       Impact factor: 5.157

10.  An avian influenza H5N1 virus that binds to a human-type receptor.

Authors:  Prasert Auewarakul; Ornpreya Suptawiwat; Alita Kongchanagul; Chak Sangma; Yasuo Suzuki; Kumnuan Ungchusak; Suda Louisirirotchanakul; Hatairat Lerdsamran; Phisanu Pooruk; Arunee Thitithanyanont; Chakrarat Pittayawonganon; Chao-Tan Guo; Hiroaki Hiramatsu; Wipawee Jampangern; Supamit Chunsutthiwat; Pilaipan Puthavathana
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

View more
  18 in total

1.  Site-specific glycosylation of the Newcastle disease virus haemagglutinin-neuraminidase.

Authors:  Cassandra L Pegg; Christine Hoogland; Jeffrey J Gorman
Journal:  Glycoconj J       Date:  2016-12-07       Impact factor: 2.916

Review 2.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

3.  NKp46 O-glycan sequences that are involved in the interaction with hemagglutinin type 1 of influenza virus.

Authors:  Michal Mendelson; Yoram Tekoah; Alon Zilka; Orly Gershoni-Yahalom; Roi Gazit; Hagit Achdout; Nicolai V Bovin; Tal Meningher; Michal Mandelboim; Ofer Mandelboim; Ayelet David; Angel Porgador
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

4.  Quadrivalent cell culture influenza virus vaccine. Comparison to egg-derived vaccine.

Authors:  Alberto Pérez-Rubio; Julio Ancochea; Jose María Eiros Bouza
Journal:  Hum Vaccin Immunother       Date:  2020-04-07       Impact factor: 3.452

5.  Cellular scent of influenza virus infection.

Authors:  Alexander A Aksenov; Christian E Sandrock; Weixiang Zhao; Shankar Sankaran; Michael Schivo; Richart Harper; Carol J Cardona; Zheng Xing; Cristina E Davis
Journal:  Chembiochem       Date:  2014-04-09       Impact factor: 3.164

6.  Binding of avian coronavirus spike proteins to host factors reflects virus tropism and pathogenicity.

Authors:  I N Ambepitiya Wickramasinghe; R P de Vries; A Gröne; C A M de Haan; M H Verheije
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

7.  Receptor specificity of influenza A H3N2 viruses isolated in mammalian cells and embryonated chicken eggs.

Authors:  James Stevens; Li-Mei Chen; Paul J Carney; Rebecca Garten; Angie Foust; Jianhua Le; Barbara A Pokorny; Ramanunninair Manojkumar; Jeanmarie Silverman; Rene Devis; Karen Rhea; Xiyan Xu; Doris J Bucher; James C Paulson; James Paulson; Nancy J Cox; Alexander Klimov; Ruben O Donis
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

Review 8.  H5N1 receptor specificity as a factor in pandemic risk.

Authors:  James C Paulson; Robert P de Vries
Journal:  Virus Res       Date:  2013-04-22       Impact factor: 3.303

9.  Sialoglycovirology of Lectins: Sialyl Glycan Binding of Enveloped and Non-enveloped Viruses.

Authors:  Nongluk Sriwilaijaroen; Yasuo Suzuki
Journal:  Methods Mol Biol       Date:  2020

10.  Influenza vaccination in the elderly boosts antibodies against conserved viral proteins and egg-produced glycans.

Authors:  Jiwon Jung; Sophia T Mundle; Irina V Ustyugova; Andrew P Horton; Daniel R Boutz; Svetlana Pougatcheva; Ponraj Prabakaran; Jonathan R McDaniel; Gregory R King; Daechan Park; Maria D Person; Congxi Ye; Bing Tan; Yuri Tanno; Jin Eyun Kim; Nicholas C Curtis; Joshua DiNapoli; Simon Delagrave; Ted M Ross; Gregory C Ippolito; Harry Kleanthous; Jiwon Lee; George Georgiou
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.